94 related articles for article (PubMed ID: 24462386)
1. Assessment of the radiation-equivalent of chemotherapy contributions in 1-phase radio-chemotherapy treatment of muscle-invasive bladder cancer.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):927-32. PubMed ID: 24462386
[TBL] [Abstract][Full Text] [Related]
2. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
4. The role of radiotherapy in the treatment of muscle invasive bladder cancer.
Porter AT
Prog Clin Biol Res; 1990; 353():23-34. PubMed ID: 2217424
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy.
Sanguineti G; Orsatti M; Sormani MP; Canobbio L; Curotto A; Tognoni P; Giudici S; Franzone P; Boccardo F; Vitale V
Cancer J Sci Am; 1997; 3(4):213-23. PubMed ID: 9263627
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.
Yoshida S; Koga F; Kobayashi S; Ishii C; Tanaka H; Tanaka H; Komai Y; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e21-7. PubMed ID: 22414281
[TBL] [Abstract][Full Text] [Related]
7. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML
Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081
[TBL] [Abstract][Full Text] [Related]
8. [Concomitant chemoradiotherapy of infiltrating cancers of the bladder].
Housset M
Cancer Radiother; 1998 Dec; 2(6):713-7. PubMed ID: 9922778
[TBL] [Abstract][Full Text] [Related]
9. Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation.
Hara T; Nishijima J; Miyachika Y; Yamamoto Y; Sakano S; Matsuyama H
Jpn J Clin Oncol; 2011 Jul; 41(7):902-7. PubMed ID: 21616918
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
11. How much radiation is the chemotherapy worth in advanced head and neck cancer?
Kasibhatla M; Kirkpatrick JP; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1491-5. PubMed ID: 17674979
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and chemotherapy in invasive bladder cancer with potential bladder sparing.
Kaufman DS; Shipley WU; Althausen AF
Hematol Oncol Clin North Am; 1992 Feb; 6(1):179-94. PubMed ID: 1556049
[TBL] [Abstract][Full Text] [Related]
13. [Current role of chemotherapy in the treatment of invasive cancers of the bladder].
Chauvet B; Davin JL; Vincent P; Alfonsi M; Serin D; Levallois M; Reboul F
Bull Cancer; 1992; 79(3):279-90. PubMed ID: 1392167
[TBL] [Abstract][Full Text] [Related]
14. Improving and predicting radiosensitivity in muscle invasive bladder cancer.
Colquhoun AJ; Jones GD; Moneef MA; Bowman KJ; Kockelbergh RC; Symonds RP; Steward WP; Mellon JK
J Urol; 2003 Jun; 169(6):1983-92. PubMed ID: 12771703
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
Choueiri TK; Raghavan D
Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
17. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
Smith MR; Kantoff PW
Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
[TBL] [Abstract][Full Text] [Related]
20. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
